XCSEDAC
Market cap4mUSD
Dec 23, Last price
2.94DKK
1D
12.21%
1Q
-12.50%
IPO
-50.17%
Name
Danish Aerospace Company A/S
Chart & Performance
Profile
Danish Aerospace Company A/S designs, develops, manufactures, and sells medical monitoring and exercise equipment. It offers agile data analyzer and monitor, a medical software that supports loading data over a network connection; portable pulmonary function systems for use in the areas of respiratory, cardiovascular, and metabolic physiology; cycle ergometer with vibration isolation and stabilization system, a recumbent bicycle that provides aerobic exercise for the harmful physiological effects of exposure to microgravity; advanced respiratory monitoring systems; European enhanced exploration exercise devices; space shuttle ergometer; and flight ergometer, the next generation space ergometer. The company also provides respiratory monitoring systems-II equipment, a photo- and magnetoacoustic multi-gas analyzer for performing non-invasive cardiovascular and pulmonary measurements; and European gas delivery system, a specially developed gas cylinder used for calibration and measurement of equipment and/or as breathing gases for use in space. Danish Aerospace Company A/S was founded in 1988 and is based in Odense, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
Income | |||||||
Revenues | 31,881 33.33% | 23,911 17.48% | 20,354 -7.78% | ||||
Cost of revenue | 27,839 | 6,078 | 5,287 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 4,042 | 17,834 | 15,067 | ||||
NOPBT Margin | 12.68% | 74.58% | 74.02% | ||||
Operating Taxes | 694 | 675 | 200 | ||||
Tax Rate | 17.18% | 3.79% | 1.32% | ||||
NOPAT | 3,348 | 17,158 | 14,867 | ||||
Net income | 2,020 8.32% | 1,865 963.85% | 175 -24.88% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
Debt | |||||||
Debt current | 15,662 | 4,906 | (30) | ||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | 1,166 | 1,126 | 1,110 | ||||
Net debt | 15,563 | 4,775 | (2,760) | ||||
Cash flow | |||||||
Cash from operating activities | (8,944) | (6,371) | 7,612 | ||||
CAPEX | (36) | (1,112) | (601) | ||||
Cash from investing activities | (1,835) | (1,112) | (601) | ||||
Cash from financing activities | 10,756 | 4,906 | (4,487) | ||||
FCF | 5,462 | 7,789 | 21,291 | ||||
Balance | |||||||
Cash | 84 | 106 | 2,683 | ||||
Long term investments | 15 | 24 | 47 | ||||
Excess cash | 1,712 | ||||||
Stockholders' equity | 12,052 | 21,306 | 19,727 | ||||
Invested Capital | 28,879 | 27,339 | 19,094 | ||||
ROIC | 11.91% | 73.91% | 66.75% | ||||
ROCE | 12.95% | 55.94% | 61.37% | ||||
EV | |||||||
Common stock shares outstanding | 10,908 | 10,908 | 10,908 | ||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | 4,539 | 18,601 | 16,201 | ||||
EV/EBITDA | |||||||
Interest | 976 | 46 | 235 | ||||
Interest/NOPBT | 24.15% | 0.26% | 1.56% |